{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:48:58Z","timestamp":1761598138059,"version":"build-2065373602"},"reference-count":64,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.hoc.2019.09.008","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T18:39:02Z","timestamp":1573843142000},"page":"189-203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Contemporary Topics in Radiation Medicine"],"prefix":"10.1016","volume":"34","author":[{"given":"Sarah J.","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy H.","family":"Decker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hoc.2019.09.008_bib1","first-page":"120","article-title":"Epidemiology of skin cancer","volume":"810","author":"Leiter","year":"2014","journal-title":"Adv Exp Med Biol"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2019.09.008_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s13555-016-0165-y","article-title":"Skin cancer: epidemiology, disease burden, pathophysiology, diagnosis, and therapeutic approaches","volume":"7","author":"Apalla","year":"2017","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.hoc.2019.09.008_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7812\/TPP\/17-181","article-title":"Invasive basal cell carcinoma of the skin treated successfully with vismodegib: a case report","volume":"22","author":"Awad","year":"2018","journal-title":"Perm J"},{"key":"10.1016\/j.hoc.2019.09.008_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/cup.13304","article-title":"Genital basal cell carcinoma, a different pathogenesis from sun-exposed basal cell carcinoma? A case-control study of 30 cases","author":"Wang","year":"2018","journal-title":"J\u00a0Cutan Pathol"},{"author":"Network, N.C.C","key":"10.1016\/j.hoc.2019.09.008_bib5"},{"issue":"8589","key":"10.1016\/j.hoc.2019.09.008_bib6","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(88)91658-3","article-title":"Malignant transformation of solar keratoses to squamous cell carcinoma","volume":"1","author":"Marks","year":"1988","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.hoc.2019.09.008_bib7","first-page":"60","article-title":"A\u00a0comprehensive review on Marjolin's ulcers: diagnosis and treatment","volume":"3","author":"Pekarek","year":"2011","journal-title":"J\u00a0Am Col Certif Wound Spec"},{"issue":"4","key":"10.1016\/j.hoc.2019.09.008_bib8","first-page":"39","article-title":"Management of high-risk cutaneous squamous cell carcinoma","volume":"3","author":"Jennings","year":"2010","journal-title":"J\u00a0Clin Aesthet Dermatol"},{"issue":"11","key":"10.1016\/j.hoc.2019.09.008_bib9","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/j.jid.2017.06.025","article-title":"Survival of patients with cutaneous squamous cell carcinoma: results of a prospective cohort study","volume":"137","author":"Eigentler","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.hoc.2019.09.008_bib10","unstructured":"AJCC cancer staging manual. In Amin MB, Edge S, Greene F, et al, Editors, 8th edition, New York: Springer Publishing."},{"issue":"4","key":"10.1016\/j.hoc.2019.09.008_bib11","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1046\/j.1365-2133.2000.03772.x","article-title":"Comparison of cryotherapy with curettage in the treatment of Bowen's disease: a prospective study","volume":"143","author":"Ahmed","year":"2000","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.hoc.2019.09.008_bib12","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2340\/00015555-2175","article-title":"A\u00a0retrospective study of treatment of squamous cell carcinoma in\u00a0situ","volume":"96","author":"Overmark","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.hoc.2019.09.008_bib13","unstructured":"Network, N.C.C., Squamous Cell Skin Cancer (Version 2.2019). 2019."},{"issue":"4","key":"10.1016\/j.hoc.2019.09.008_bib14","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMra1708701","article-title":"Update on keratinocyte carcinomas","volume":"379","author":"Nehal","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.hoc.2019.09.008_bib15","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/hed.20991","article-title":"Radiotherapy for perineural invasion in cutaneous head and neck carcinomas: toward a risk-adapted treatment approach","volume":"31","author":"Jackson","year":"2009","journal-title":"Head Neck"},{"issue":"10","key":"10.1016\/j.hoc.2019.09.008_bib16","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/j.1524-4725.2009.01276.x","article-title":"Treatment of cutaneous squamous cell carcinoma with perineural invasion using Mohs micrographic surgery: report of two cases and review of the literature","volume":"35","author":"Reule","year":"2009","journal-title":"Dermatol Surg"},{"issue":"6","key":"10.1016\/j.hoc.2019.09.008_bib17","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/cncr.22509","article-title":"What is the role of adjuvant radiotherapy in the treatment of cutaneous squamous cell carcinoma with perineural invasion?","volume":"109","author":"Han","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2019.09.008_bib18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.37549\/ARO1124","article-title":"A review of the role of external-beam radiation therapy in nonmelanomatous skin cancer","volume":"6","author":"Manyam","year":"2017","journal-title":"Appl Rad Oncol"},{"key":"10.1016\/j.hoc.2019.09.008_bib19","series-title":"Clinical radiation oncology","first-page":"763","article-title":"Cutaneous carcinomas","author":"Howle","year":"2015"},{"issue":"13","key":"10.1016\/j.hoc.2019.09.008_bib20","doi-asserted-by":"crossref","first-page":"R455","DOI":"10.1088\/0031-9155\/51\/13\/R25","article-title":"Review of electron beam therapy physics","volume":"51","author":"Hogstrom","year":"2006","journal-title":"Phys Med Biol"},{"issue":"2","key":"10.1016\/j.hoc.2019.09.008_bib21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.radonc.2010.02.024","article-title":"Efficacy of a hypofractionated schedule in electron beam radiotherapy for epithelial skin cancer: analysis of 434 cases","volume":"95","author":"van Hezewijk","year":"2010","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2019.09.008_bib22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.radonc.2012.06.013","article-title":"Recommendations for CTV margins in radiotherapy planning for non melanoma skin cancer","volume":"104","author":"Khan","year":"2012","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2019.09.008_bib23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ijrobp.2008.06.1943","article-title":"Skin cancer of the head and neck with perineural invasion: defining the clinical target volumes based on the pattern of failure","volume":"74","author":"Gluck","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.hoc.2019.09.008_bib24","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.radonc.2017.12.029","article-title":"Skin CanceR Brachytherapy vs External beam radiation therapy (SCRiBE) meta-analysis","volume":"126","author":"Zaorsky","year":"2018","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2019.09.008_bib25","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.brachy.2015.06.005","article-title":"Aspects of dosimetry and clinical practice of skin brachytherapy: the American Brachytherapy Society working group report","volume":"14","author":"Ouhib","year":"2015","journal-title":"Brachytherapy"},{"issue":"5","key":"10.1016\/j.hoc.2019.09.008_bib26","doi-asserted-by":"crossref","first-page":"362","DOI":"10.5114\/pdia.2015.54746","article-title":"Brachytherapy in the treatment of skin cancer: an overview","volume":"32","author":"Skowronek","year":"2015","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.hoc.2019.09.008_bib27","unstructured":"Available at: http:\/\/www.cancer.gov\/types\/skin\/moles-fact-sheet. Accessed March 24, 2019."},{"issue":"5","key":"10.1016\/j.hoc.2019.09.008_bib28","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/00000658-197011000-00017","article-title":"Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma","volume":"172","author":"Breslow","year":"1970","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.hoc.2019.09.008_bib29","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/cncr.22126","article-title":"The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003","volume":"107","author":"Lasithiotakis","year":"2006","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.hoc.2019.09.008_bib30","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1200\/JCO.2010.32.4327","article-title":"Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma","volume":"29","author":"Long","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"author":"Network, N.C.C","key":"10.1016\/j.hoc.2019.09.008_bib31"},{"issue":"2","key":"10.1016\/j.hoc.2019.09.008_bib32","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1365-2133.2010.09883.x","article-title":"Revised U.K. guidelines for the management of cutaneous melanoma 2010","volume":"163","author":"Marsden","year":"2010","journal-title":"Br J Dermatol"},{"issue":"30","key":"10.1016\/j.hoc.2019.09.008_bib33","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.1200\/JCO.2008.19.0033","article-title":"Rotterdam criteria for sentinel node (SN) tumor burden and the accuracy of ultrasound (US)-guided fine-needle aspiration cytology (FNAC): can US-guided FNAC replace SN staging in patients with melanoma?","volume":"27","author":"Voit","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.hoc.2019.09.008_bib34","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S1470-2045(15)00187-4","article-title":"Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02\/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial","volume":"16","author":"Henderson","year":"2015","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.hoc.2019.09.008_bib35","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.humpath.2014.12.001","article-title":"Merkel cell carcinoma: histopathologic and prognostic features according to the immunohistochemical expression of Merkel cell polyomavirus large T antigen correlated with viral load","volume":"46","author":"Leroux-Kozal","year":"2015","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.hoc.2019.09.008_bib36","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jaad.2007.11.020","article-title":"Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features","volume":"58","author":"Heath","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.hoc.2019.09.008_bib37","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00405-014-2974-x","article-title":"Management of Merkel cell carcinoma of unknown primary origin: the Vienna Medical School experience","volume":"272","author":"Haymerle","year":"2015","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"7","key":"10.1016\/j.hoc.2019.09.008_bib38","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1001\/jamadermatol.2013.8116","article-title":"Effect of host, tumor, diagnostic, and treatment variables on outcomes in a large cohort with Merkel cell carcinoma","volume":"150","author":"Asgari","year":"2014","journal-title":"JAMA Dermatol"},{"author":"Network, N.C.C","key":"10.1016\/j.hoc.2019.09.008_bib39"},{"issue":"9","key":"10.1016\/j.hoc.2019.09.008_bib40","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1002\/cncr.23874","article-title":"Merkel cell carcinoma: histologic features and prognosis","volume":"113","author":"Andea","year":"2008","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.hoc.2019.09.008_bib41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/ajd.12400","volume":"58","author":"Liu","year":"2017","journal-title":"Australas J Dermatol"},{"issue":"9","key":"10.1016\/j.hoc.2019.09.008_bib42","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw042","article-title":"Adjuvant radiation therapy and chemotherapy in Merkel cell carcinoma: survival analyses of 6908 cases from the national cancer data base","volume":"108","author":"Bhatia","year":"2016","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.hoc.2019.09.008_bib43","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1586\/edm.11.40","article-title":"Radiation therapy in the management of Merkel cell carcinoma: current perspectives","volume":"6","author":"Rush","year":"2011","journal-title":"Expert Rev Dermatol"},{"key":"10.1016\/j.hoc.2019.09.008_bib44","first-page":"176173","article-title":"Role of sentinel lymph node biopsy in the management of Merkel cell carcinoma","volume":"2012","author":"Arruda","year":"2012","journal-title":"J\u00a0Skin Cancer"},{"issue":"9","key":"10.1016\/j.hoc.2019.09.008_bib45","doi-asserted-by":"crossref","first-page":"e180077","DOI":"10.1001\/jamaoncol.2018.0077","article-title":"Efficacy and safety of first-line avelumab treatment in patients with stage IV metastatic Merkel cell carcinoma: a preplanned interim analysis of a clinical trial","volume":"4","author":"D'Angelo","year":"2018","journal-title":"JAMA Oncol"},{"issue":"26","key":"10.1016\/j.hoc.2019.09.008_bib46","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa1603702","article-title":"PD-1 blockade with pembrolizumab in advanced Merkel-cell carcinoma","volume":"374","author":"Nghiem","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.hoc.2019.09.008_bib47","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/ajh.24233","article-title":"Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management","volume":"91","author":"Wilcox","year":"2016","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.hoc.2019.09.008_bib48","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/(SICI)1097-0142(19990101)85:1<208::AID-CNCR28>3.0.CO;2-2","article-title":"The changing survival of patients with mycosis fungoides: a population-based assessment of trends in the United States","volume":"85","author":"Weinstock","year":"1999","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.hoc.2019.09.008_bib49","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1590\/S0365-05962012000600001","article-title":"Mycosis fungoides and S\u00e9zary syndrome: clinical, histopathological and immunohistochemical review and update","volume":"87","author":"Yamashita","year":"2012","journal-title":"An Bras Dermatol"},{"issue":"9616","key":"10.1016\/j.hoc.2019.09.008_bib50","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(08)60420-1","article-title":"Mycosis fungoides and Sezary syndrome","volume":"371","author":"Hwang","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2019.09.008_bib51","series-title":"Clinical radiation oncology","first-page":"1556","article-title":"Mycosis fungoides","author":"Grace","year":"2015"},{"issue":"3","key":"10.1016\/j.hoc.2019.09.008_bib52","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1200\/JCO.2001.19.3.779","article-title":"Clinical characteristics and outcome of patients with extracutaneous mycosis fungoides","volume":"19","author":"de Coninck","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.hoc.2019.09.008_bib53","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1182\/blood.V92.4.1150","article-title":"Transformation of mycosis fungoides\/Sezary syndrome: clinical characteristics and prognosis","volume":"92","author":"Diamandidou","year":"1998","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2019.09.008_bib54","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1067\/mjd.2002.118538","article-title":"Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas","volume":"46","author":"Vonderheid","year":"2002","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.hoc.2019.09.008_bib55","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2019.09.008_bib56","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijrobp.2015.01.008","article-title":"Modern radiation therapy for primary cutaneous lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group","volume":"92","author":"Specht","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.hoc.2019.09.008_bib57","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/0360-3016(83)90321-8","article-title":"Palliative radiation treatment of cutaneous mycosis fungoides--a dose response","volume":"9","author":"Cotter","year":"1983","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.hoc.2019.09.008_bib58","doi-asserted-by":"crossref","first-page":"e651","DOI":"10.1016\/j.ijrobp.2011.01.023","article-title":"Revisiting low-dose total skin electron beam therapy in mycosis fungoides","volume":"81","author":"Harrison","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.hoc.2019.09.008_bib59","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1067\/mjd.2002.123482","article-title":"Total skin electron radiation in the management of mycosis fungoides: consensus of the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Project Group","volume":"47","author":"Jones","year":"2002","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.hoc.2019.09.008_bib60","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood-2008-04-152850","article-title":"European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas","volume":"112","author":"Senff","year":"2008","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.hoc.2019.09.008_bib61","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1001\/archderm.143.9.1144","article-title":"Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases","volume":"143","author":"Grange","year":"2007","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.hoc.2019.09.008_bib62","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1001\/jamadermatol.2013.7452","article-title":"Improvement of survival in patients with primary cutaneous diffuse large B-cell lymphoma, leg type, in France","volume":"150","author":"Grange","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.hoc.2019.09.008_bib63","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1182\/blood-2006-10-054601","volume":"110","author":"Kim","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2019.09.008_bib64","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijrobp.2008.06.1918","article-title":"Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas","volume":"74","author":"Neelis","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858819301236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858819301236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:14:49Z","timestamp":1760184889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858819301236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0889858819301236"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2019.09.008","relation":{},"ISSN":["0889-8588"],"issn-type":[{"type":"print","value":"0889-8588"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contemporary Topics in Radiation Medicine","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2019.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}